Clinical Trial Update: Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether oral rabeprazole reduces ulcer bleeding after endoscopic mucosal resection. The study population includes patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Rabeprazole (rabeprazole)

Snippet

Sponsor: The Catholic University of Korea | Conditions: Early Gastric Adenocarcinoma, Adenocarcinoma, Tubular | Phase 4 | Status: COMPLETED